Lacosamide Accord

Lacosamide, the active ingredient in Lacosamide Accord, is an anticonvulsant presented as an oral tablet for oral use. It is used as adjunctive therapy for partial‑onset seizures in patients with epilepsy.

GNH USA supplies Lacosamide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant indicated for the treatment of focal seizure disorders.

- Partial‑onset seizures: used as adjunctive therapy to reduce seizure frequency in patients with epilepsy. - Focal epilepsy: added to existing regimens to improve seizure control. - Adjunctive therapy in epilepsy: enhances overall seizure management when combined with other antiepileptic drugs.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Nausea - Fatigue - Headache

Serious or Rare Side Effects: - Cardiac conduction abnormalities (e.g., PR‑interval prolongation) - Atrial fibrillation - Severe skin reactions such as Stevens‑Johnson syndrome

When prescribing lacosamide, several safety considerations are recommended.

- Cardiac monitoring: assess ECG for PR‑interval changes, especially in patients with cardiac disease. - Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic disease: use caution and consider dose modification. - Discontinuation: avoid abrupt cessation to reduce risk of seizure recurrence. - Suicidal ideation: monitor patients for mood changes. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Lacosamide can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin): may markedly reduce lacosamide plasma levels. - Concurrent use with other sodium‑channel blockers: may increase risk of CNS depression.

Moderate Interactions (Monitor Closely):\n- CYP2C19 inhibitors (e.g., fluoxetine, omeprazole): may increase lacosamide exposure. - Alcohol: can enhance central nervous system side effects. - Anticoagulants (e.g., warfarin): may require monitoring of coagulation parameters.